Comparable stake leader
Sofinnova Venture Partners X, L.P.
SEC ownership of CinCor Pharma, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001868734.
Disclosed value leader
Sofinnova Venture Partners X, L.P.
Comparable rows
0/6
Latest evidence
15 Aug 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Sofinnova Venture Partners X, L.P.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
15 Aug 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001868734
- Issuer location
- Waltham, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CinCor Pharma, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sofinnova Venture Partner...
Disclosed value leader
Sofinnova Venture Partner...
Comparable rows
0/6
Latest evidence
15 Aug 2022
3/4/5
Highest disclosed value: $174,626,034
6 rows are not safely comparable across share classes.
Quick read
Sofinnova Venture Partners X, L.P. has the largest disclosed position value at $174.63M.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sofinnova Venture Partners X, L.P.'s linked filing trail.
Disclosed position value
Top 5
Sofinnova Venture Partners X, L.P.
$174.63M
GENERAL ATLANTIC GENPAR (BERMUDA)...
$126.28M
GENERAL ATLANTIC, L.P.
$126.28M
Sofinnova Partners SAS
$121.35M
CinRx Pharma, LLC
$104.37M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sofinnova Venture Partners X, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$174,626,034
6,073,949 shares
|
— | 11 Aug 2022 |
| GENERAL ATLANTIC GENPAR (BERMUDA), L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$126,284,100
4,209,470 shares
|
— | 11 Aug 2022 |
| GENERAL ATLANTIC, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$126,284,100
4,209,470 shares
|
— | 11 Aug 2022 |
| Sofinnova Partners SAS |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$121,353,146
4,220,979 shares
|
— | 15 Aug 2022 |
| CinRx Pharma, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$104,365,461
3,630,103 shares
|
— | 11 Jan 2022 |
| Mary Theresa Coelho |
3/4/5
EVP CFO & Chief BD Officer
|
—
class O/S missing
|
$2,875
100 shares
|
— | 11 Jan 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to CinCor Pharma, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Sofinnova Venture Partners X, L.P.
Net 12M change
$0
Latest report
24 Feb 2023
Recent insider transactions for CinCor Pharma, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.